Kesch C, Hadaschik BA. Re: Active Surveillance Plus Enzalutamide Monotherapy vs Active Surveillance Alone in Patients with Low-risk or Intermediate-risk Localized Prostate Cancer: The ENACT Randomized Clinical Trial. Eur Urol 2022 Aug 9. pii: S0302-2838(22)02546.
PMID: 35961870